Priskila, D. et al. 2026. Molecular Simulation-Based Drug Repurposing of Thioridazine and Losartan for Targeting CXCR4 and CCR5 Chemokine Receptors in Breast Cancer. Journal of Science and Technology. 18, 1 (Jun. 2026), 69–91.